From Coronavirus to cancer, America’s innovation community is mobilized like never before. We spoke to the senior director of Health and Drug Policy, Kelly Anderson, with the U.S. Chamber of Commerce Global Innovation Policy Center.
This segment is paid for by the U.S. Chamber of Commerce